| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-146 |
Sentence |
denotes |
Fetal hemoglobin expression in the compound heterozygous state for -117 (G-->A) Agamma HPFH and IVSII-745 (C-->G) beta+ thalassemia: a case study. |
| T1 |
0-146 |
Sentence |
denotes |
Fetal hemoglobin expression in the compound heterozygous state for -117 (G-->A) Agamma HPFH and IVSII-745 (C-->G) beta+ thalassemia: a case study. |
| TextSentencer_T2 |
147-240 |
Sentence |
denotes |
We studied a family in which two inherited defects of the non-alpha-globin cluster segregate: |
| T2 |
147-240 |
Sentence |
denotes |
We studied a family in which two inherited defects of the non-alpha-globin cluster segregate: |
| TextSentencer_T3 |
241-318 |
Sentence |
denotes |
Greek hereditary persistence of fetal hemoglobin (HPFH) and beta-thalassemia. |
| T3 |
241-318 |
Sentence |
denotes |
Greek hereditary persistence of fetal hemoglobin (HPFH) and beta-thalassemia. |
| TextSentencer_T4 |
319-616 |
Sentence |
denotes |
The compound heterozygote is a healthy man with 43% HbF, Ggamma/Agamma ratio (27:73) differing from that of 10 simple heterozygotes for the Greek HPFH (92:8), normal levels of total Hb (13.3 g/dl), and reduced HbA2 levels comparing with the levels of beta-thal heterozygotes for the same mutation. |
| T4 |
319-616 |
Sentence |
denotes |
The compound heterozygote is a healthy man with 43% HbF, Ggamma/Agamma ratio (27:73) differing from that of 10 simple heterozygotes for the Greek HPFH (92:8), normal levels of total Hb (13.3 g/dl), and reduced HbA2 levels comparing with the levels of beta-thal heterozygotes for the same mutation. |
| TextSentencer_T5 |
617-777 |
Sentence |
denotes |
Molecular analysis of the beta-globin genotype revealed the presence of the IVSII-745 (C-->G) beta+ RNA splice mutation in trans with the -117 G-->A Greek HPFH. |
| T5 |
617-777 |
Sentence |
denotes |
Molecular analysis of the beta-globin genotype revealed the presence of the IVSII-745 (C-->G) beta+ RNA splice mutation in trans with the -117 G-->A Greek HPFH. |
| TextSentencer_T6 |
778-877 |
Sentence |
denotes |
The beta+ mutation was linked to haplotype VII and the Greek HPFH was associated with haplotype Ia. |
| T6 |
778-877 |
Sentence |
denotes |
The beta+ mutation was linked to haplotype VII and the Greek HPFH was associated with haplotype Ia. |
| TextSentencer_T7 |
878-1028 |
Sentence |
denotes |
The father of the compound heterozygote carries the Greek HPFH in trans with the -158 C-->T on the Ggamma promoter, which is linked with haplotype IV. |
| T7 |
878-1028 |
Sentence |
denotes |
The father of the compound heterozygote carries the Greek HPFH in trans with the -158 C-->T on the Ggamma promoter, which is linked with haplotype IV. |
| TextSentencer_T8 |
1029-1085 |
Sentence |
denotes |
He presented 13.5% HbF with a Ggamma/Agamma ratio 75:25. |
| T8 |
1029-1085 |
Sentence |
denotes |
He presented 13.5% HbF with a Ggamma/Agamma ratio 75:25. |
| TextSentencer_T9 |
1086-1248 |
Sentence |
denotes |
His daughter was a compound heterozygote for the IVSII-745 mutation in trans with the -158 C-->T, while her HbF levels were 3.7% with a Ggamma/Agamma ratio 31:69. |
| T9 |
1086-1248 |
Sentence |
denotes |
His daughter was a compound heterozygote for the IVSII-745 mutation in trans with the -158 C-->T, while her HbF levels were 3.7% with a Ggamma/Agamma ratio 31:69. |